Evotec SE EVT.VI Stock
Evotec SE Price Chart
Evotec SE EVT.VI Financial and Trading Overview
| Evotec SE stock price | 13.77 EUR |
| Previous Close | 21.73 EUR |
| Open | 21.97 EUR |
| Bid | 21.4 EUR x 0 |
| Ask | 21.67 EUR x 0 |
| Day's Range | 21.97 - 21.97 EUR |
| 52 Week Range | 14.94 - 29.11 EUR |
| Volume | 0 EUR |
| Avg. Volume | 3 EUR |
| Market Cap | 3.89B EUR |
| Beta (5Y Monthly) | 0.99272 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.53 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EVT.VI Valuation Measures
| Enterprise Value | 3.67B EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.1735544 |
| Price/Book (mrq) | 3.269832 |
| Enterprise Value/Revenue | 4.882 |
| Enterprise Value/EBITDA | 44.865 |
Trading Information
Evotec SE Stock Price History
| Beta (5Y Monthly) | 0.99272 |
| 52-Week Change | -6.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 29.11 EUR |
| 52 Week Low | 14.94 EUR |
| 50-Day Moving Average | 19.27 EUR |
| 200-Day Moving Average | 18.23 EUR |
EVT.VI Share Statistics
| Avg. Volume (3 month) | 3 EUR |
| Avg. Daily Volume (10-Days) | 6 EUR |
| Shares Outstanding | 176.95M |
| Float | 143.13M |
| Short Ratio | N/A |
| % Held by Insiders | 10.06% |
| % Held by Institutions | 59.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -23.37% |
| Operating Margin (ttm) | 2.70% |
| Gross Margin | 23.16% |
| EBITDA Margin | 10.88% |
Management Effectiveness
| Return on Assets (ttm) | 0.56% |
| Return on Equity (ttm) | -13.69% |
Income Statement
| Revenue (ttm) | 751.45M EUR |
| Revenue Per Share (ttm) | 4.25 EUR |
| Quarterly Revenue Growth (yoy) | 28.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | 81.77M EUR |
| Net Income Avi to Common (ttm) | -175655008 EUR |
| Diluted EPS (ttm) | -1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 718.49M EUR |
| Total Cash Per Share (mrq) | 4.07 EUR |
| Total Debt (mrq) | 506.67M EUR |
| Total Debt/Equity (mrq) | 42.68 EUR |
| Current Ratio (mrq) | 3.179 |
| Book Value Per Share (mrq) | 6.719 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 203.11M EUR |
| Levered Free Cash Flow (ttm) | -150347744 EUR |
Profile of Evotec SE
| Country | Austria |
| State | N/A |
| City | Hamburg |
| Address | Essener Bogen 7 |
| ZIP | 22419 |
| Phone | 49 40 560 81 0 |
| Website | https://www.evotec.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 4952 |
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Q&A For Evotec SE Stock
What is a current EVT.VI stock price?
Evotec SE EVT.VI stock price today per share is 13.77 EUR.
How to purchase Evotec SE stock?
You can buy EVT.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evotec SE?
The stock symbol or ticker of Evotec SE is EVT.VI.
Which industry does the Evotec SE company belong to?
The Evotec SE industry is Drug Manufacturers-Specialty & Generic.
How many shares does Evotec SE have in circulation?
The max supply of Evotec SE shares is 177.19M.
What is Evotec SE Price to Earnings Ratio (PE Ratio)?
Evotec SE PE Ratio is now.
What was Evotec SE earnings per share over the trailing 12 months (TTM)?
Evotec SE EPS is -0.53 EUR over the trailing 12 months.
Which sector does the Evotec SE company belong to?
The Evotec SE sector is Healthcare.